Cesca: CESCA THERAPEUTICS INC. (NASDAQ:KOOL) Files An 8-K Regulation FD Disclosure
On September 10, 2019, Cesca Therapeutics Inc., (the “Company”) provided an update to its corporate presentation. The presentation will be available on the Company’s website at www.cescatherapeutics.com and filed herewith as Exhibit 99.1.
Read full article »
Cesca develops and commercializes cell-based therapeutics for the treatment of immuno-oncology, vascular, cardiology and orthopedic diseases.
Read more